In vivo imaging xenograft models for the evaluation of anti‐brain tumor efficacy of targeted drugs

類似資料

• Glycogen synthase kinase‐3 inhibition overcomes epithelial‐mesenchymal transition‐associated resistance to osimertinib in EGFR‐mutant lung cancer
  著者:: Fukuda, Koji, 等
  出版事項: (2020)
• High efficacy of third generation EGFR inhibitor AZD9291 in a leptomeningeal carcinomatosis model with EGFR-mutant lung cancer cells
  著者:: Nanjo, Shigeki, 等
  出版事項: (2015)
• Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib‐resistance of EML4‐ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors
  著者:: Taniguchi, Hirokazu, 等
  出版事項: (2016)
• Impact of MET inhibition on small‐cell lung cancer cells showing aberrant activation of the hepatocyte growth factor/MET pathway
  著者:: Taniguchi, Hirokazu, 等
  出版事項: (2017)
• Patient‐derived xenograft models of non‐small cell lung cancer for evaluating targeted drug sensitivity and resistance
  著者:: Kita, Kenji, 等
  出版事項: (2019)